Abstract
Gitelman’s syndrome (GS) is a rare, autosomal recessive, salt-losing tubulopathy caused by mutations in the SLC12A3 gene, which encodes the thiazide-sensitive NaCl cotransporter (NCC). Because 18 to 40% of suspected GS patients carry only one SLC12A3 mutant allele, large genomic rearrangements may account for unidentified mutations. Here, we directly sequenced genomic DNA from a large cohort of 448 unrelated patients suspected of having GS. We found 172 distinct mutations, of which 100 were unreported previously. In 315 patients (70%), we identified two mutations; in 81 patients (18%), we identified one; and in 52 patients (12%), we did not detect a mutation. In 88 patients, we performed a search for large rearrangements by multiplex ligation-dependent probe amplification (MLPA) and found nine deletions and two duplications in 24 of the 51 heterozygous patients. A second technique confirmed each rearrangement. Based on the breakpoints of seven deletions, nonallelic homologous recombination by Alu sequences and nonhomologous end-joining probably favor these intragenic deletions. In summary, missense mutations account for approximately 59% of the mutations in Gitelman’s syndrome, and there is a predisposition to large rearrangements (6% of our cases) caused by the presence of repeated sequences within the SLC12A3 gene.
Similar content being viewed by others
References
Ji W, Foo JN, O’Roak BJ, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet. 2008;40(5):592–9.
Assistance Publique - Hôpitaux de Paris, Blanchard A. Input of the use of indometacin in Gitelman syndrome as compared to potassium sparing diuretics (GITAB). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2011 [cited 2011 May 5]. Available from: http://clinicaltrials.gov/ct2/show/NCT01146197, NLM Identifier: NCT01146197.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hollenberg, N.K. Improving Genetic Testing for Gitelman’s Syndrome. Curr Hypertens Rep 13, 328–329 (2011). https://doi.org/10.1007/s11906-011-0213-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11906-011-0213-z